Suhail M Ali

Title: Innovations in Cancer Monitoring by Suhail M Ali

Introduction

Suhail M Ali is an accomplished inventor based in Hershey, PA (US). He has made significant contributions to the field of cancer patient monitoring through his innovative patent. His work focuses on improving the methods used to assess the effectiveness of cancer treatments.

Latest Patents

Suhail M Ali holds a patent for "Assays for cancer patient monitoring based on levels of epidermal growth factor receptor (EGFR) extracellular domain (ECD) analyte, alone or in combination with other analytes, in body fluid samples." This invention describes clinically and medically important methods for monitoring the outcome of cancer patients. It provides a method for assessing the progression of disease or the effectiveness of cancer treatment by measuring the level of the EGFR ECD in patient samples. A decrease in the level of EGFR ECD compared to normal control individuals serves as an indicator of cancer advancement or treatment effectiveness. Additionally, the invention assesses both EGFR and HER-2/neu levels in combination to determine disease outcome and survival.

Career Highlights

Suhail M Ali is currently associated with Siemens Healthcare Diagnostics GmbH, where he continues to work on innovative solutions in healthcare diagnostics. His expertise in cancer monitoring has positioned him as a valuable contributor to advancements in medical technology.

Collaborations

Suhail has collaborated with notable colleagues, including Walter P Carney and Peter J Hamer, to further enhance the impact of his work in the field of cancer diagnostics.

Conclusion

Suhail M Ali's innovative approach to cancer patient monitoring through his patent demonstrates his commitment to improving healthcare outcomes. His contributions are vital in the ongoing battle against cancer, providing new methods for assessing treatment effectiveness and disease progression.